Keyword: patent

Brevity: Headers | « Text »
  • ANTHONY FAUCI HOLDS PATENTS ON HIV COMPONENT USED TO CREATE COVID-19

    08/12/2021 6:29:36 AM PDT · by Red Badger · 49 replies
    https://www.organiclifestylemagazine.com ^ | June 29, 2021 | by Sage Edwards
    Dr. Anthony Fauci’s name appears on four U.S patents for a key glycoprotein that seems to have been inserted into the SARS virus to create COVID-19. Justia.com, a legal portal, lists patents by inventor Anthony Fauci involving a glycoprotein in HIV-1. This same glycoprotein, identified as Glycoprotein 120, or simply as GP120, has also been found to be a key component of the current COVID-19, a disease that appears to combine a HIV-1 attack on the human immune system, with SARS CoV-1, the pathogen from the original SARS Medical scientists in India reported four intersections in the spike glycoprotein that...
  • Patents are the smoking gun

    07/22/2021 2:12:22 PM PDT · by stonehouse01 · 14 replies
    brandnewtube.com ^ | July 9, 2021 | Dr. David Martin Reiner
    "The first vaccine ever patented for coronavirus was actually sought by Pfizer ... twenty one years ago"
  • NEW: Wuhan's 'Bat Woman' Worked With Chinese Military on Weaponizing Coronaviruses Using US Government Money

    06/30/2021 6:12:27 PM PDT · by SeekAndFind · 15 replies
    Red State ^ | 06/30/2021 | Jennifer Van Laar
    As the walls are closing in on those who’ve attempted to deflect, discredit, and ignore the evidence over the last 18 months that SARS-CoV-2 was engineered at the Wuhan Institute of Virology, a few legacy media organizations are starting to report what we’ve reported for a few months and bringing the receipts – sort of.As the New York Post reported on June 4 (and which RedState’s Scott Hounsell elaborated on later), a Chinese military scientist named Zhou Yusen filed for a patent for a coronavirus vaccine on behalf of the People’s Liberation Army in February 2020, only five weeks after...
  • Watch Out for a Vaccine Patent Heist

    Pharmaceutical companies have come to the world’s rescue with Covid-19 vaccines, but these days no good deed by business goes unpunished. The Biden Administration is now under pressure to support a political campaign to break vaccine patents. India and South Africa last fall petitioned the World Trade Organization to suspend intellectual property protections on Covid vaccines and treatments, which they say is necessary to expand global access. Fifty-five other countries plus an army of nonprofiits and labor unions have joined the attempted heist. “Multibillion-dollar pharmaceutical companies continue to prioritize profits by protecting their monopolies,” Bernie Sanders says. Adds Connecticut Rep....
  • Mysterious New Warp Drive Patent Surfaces Online

    03/05/2021 8:32:30 AM PST · by Roman_War_Criminal · 47 replies
    thedebrief.org ^ | 3/2/21 | Christopher Plain
    After appearing for decades in science fiction, then moving into an actual theory, a new patent for an updated warp drive was published last year to no fanfare. Like many other false starts in cutting-edge research, the patent may represent the next step in the expanding theory, or it could mean the practical, real-world design of a functioning warp drive is on the horizon. BACKGROUND: HOW TO BEND SPACE-TIME WITH A WARP DRIVE After first publishing his groundbreaking 1994 warp drive concept in the journal Classical and Quantum Gravity, Mexican Mathematician and Physicist Miguel Alcubierre received significant positive and negative...
  • U.S. Navy Has Patents on Tech It Says Will ‘Engineer the Fabric of Reality’

    02/05/2021 1:25:49 PM PST · by yesthatjallen · 34 replies
    Vice ^ | 02 03 2021 | Matthew Gault
    The U.S. Navy has patents on weird and little understood technology. According to patents filed by the Navy, it is working on a compact fusion reactor that could power cities, an engine that works using “inertial mass reduction,” and a “hybrid aerospace-underwater craft.” Dubbed the “UFO patents, The War Zone has reported that the Navy had to build prototypes of some of the outlandish tech to prove it worked. Dr. Salvatore Cezar Pais is the man behind the patents and The War Zone has proven the man exists, at least on paper. Pais has worked for a number of different...
  • Professor of Molecular Genetics issues ‘chilling warning’ on Covid mRNA vaccines…

    01/28/2021 5:30:49 AM PST · by Red Badger · 112 replies
    https://citizenfreepress.com ^ | Posted by Kane on January 28, 2021 4:25 am
    SOURCE — LEW ROCKWELL Latent Deaths Predicted Among The Elderly After Immunization With mRNA Vaccine Dr. Dolores Cahill, professor of molecular genetics, School of Medicine at University College Dublin, and chairwoman of Irish Freedom Party, Dolores Cahill PhD speaking about mRNA vaccines Partial Transcript Then the real adverse events will happen, against whatever is the real mRNA in the vaccines, and when the person vaccinated comes across (this coronavirus) sometime later …. what happened in the animal studies, 20% or 50% or 100% of the animals died. Among people over 80, maybe about 2.5% will experience severe side effects, adverse...
  • Covid-19 Vaccine Developer Moderna Lost a Patent Case and the Stock Is Stumbling

    07/24/2020 8:38:15 AM PDT · by SeekAndFind · 7 replies
    Barrons ^ | 07/24/2020 | By Josh Nathan-Kazis
    Moderna lost a patent case on Thursday that had been all but overlooked as the stock surged on excitement around the company’s Covid-19 vaccine, which is set to be tested in a large Phase 3 trial beginning next week. What the decision handed down Thursday by the Patent Trial and Appeal Board could mean for Moderna (ticker: MRNA) isn’t yet clear, but the stock fell 9.5% on Thursday, and was down another 5% Friday in premarket trading. “This legal dispute has been an ongoing debate among investors, and today’s decision is a disappointing turn for MRNA,” wrote SVB Leerink analyst...
  • China’s Wuhan Institute Files to Patent the Use of Gilead’s Remdesivir for Coronavirus

    04/30/2020 8:49:09 AM PDT · by conservative98 · 41 replies
    Biospace ^ | Published: Feb 05, 2020 | By Mark Terry
    The Wuhan Institute of Virology, part of the China Academy of Sciences, has applied to patent the use of Gilead Sciences’ remdesivir to treat the current coronavirus outbreak. The company has partnered with Chinese health authorities to run a Phase III clinical trial to assess remdesivir for treatment of the virus. The drug was originally developed to treat the Ebola virus, but wasn’t effective. Preclinical assays have suggested that the drug might be effective against the coronavirus, 2019-nCoV, as was published in the New England Journal of Medicine (NEJM). The drug was given to a U.S. patient for compassionate use...
  • Israeli scientist awarded US patent for coronavirus vaccine

    04/21/2020 4:45:27 PM PDT · by Eleutheria5 · 24 replies
    Arutz Sheva ^ | 22/4/20
    Tel Aviv University researcher has just received a patent from the USPTO for his innovative vaccine design for the corona family... Video https://www.youtube.com/watch?time_continue=4&v=CUVuL8KBZB0&feature=emb_logo
  • I need this explained to me: Why is Remdesivir an improvement over HCQ/Zinc/Antibiotics?

    04/17/2020 6:20:15 AM PDT · by RinaseaofDs · 132 replies
    4/17/2020 | Vanity
    We have an effective therapy, have had it since before 2009. Fauci begged to use HCQ during the MERS outbreak in 2009. Now we have SARS-2, the Wuhan Boogaloo. We have a MOUNTAIN of empirical evidence that HCQ/Zinc is prophylactic and HCQ/Zinc/Antibiotic is a therapy for the infected. Remdesivir is tested on 125 people with good results (and two deaths), but NOW there's hope? Sorry, smells horrible.
  • Who owns the coronavirus cure? China’s move to patent Gilead’s experimental drug for the novel virus could lead to legal wrangle

    02/06/2020 7:05:07 AM PST · by Zhang Fei · 16 replies
    South China Morning Post ^ | Published: 8:00am, 6 Feb, 2020 Updated: 1:17pm, 6 Feb, 2020 | Eric Ng
    China has applied to patent a drug candidate being developed by Gilead Sciences as the government rushes to find the cure for the deadly coronavirus, a move that could raise questions on intellectual property and marketing rights. The state-backed Institute of Virology in Wuhan filed the patent for using remdesivir to fight the novel coronavirus on January 21, according to a statement posted on its website two weeks later on February 4. If approved, the drug will be used to facilitate its potential global market entry, it added. Studies have been conducted outside the human bodies and found that Gilead’s...
  • Coronavirus Patent (10130701)

    03/03/2020 7:42:43 AM PST · by RBW in PA · 27 replies
    Apparently a patent (Number 10130701) for the Coronavirus was filed in July of 2015 by the Pirbright Institute (Bill Gates). If I'm reading the form correctly the patent was awarded in November of 2018. I'd like to think that this is not the same variant that is spreading to humans, but found it interesting that people were actually working on this. No conspiracy, just thought I'd share a bit of information. Coronavirus Patent
  • Amazon wants to patent device that IDs shoppers by their hand

    12/29/2019 4:28:11 PM PST · by DFG · 67 replies
    NY Post ^ | 12/27/2019 | Nicolas Vega
    Amazon is one step closer to implementing its creepy, futuristic flesh-and-blood payment system. The e-tailing giant’s engineers on Thursday filed a patent application for a device that can scan a human hand — without ever touching it — as a way to ring up a store purchase. As The Post exclusively reported in September, the device is being developed by Amazon engineers under the code name “Orville” for a future rollout at the Amazon-owned Whole Foods supermarket chain. Employees at Amazon’s New York offices have been serving as guinea pigs for the biometric technology, using it at a handful of...
  • In patent cases, imposing attorney fees will ‘hamper equal access to justice,’ ABA says

    10/07/2019 8:47:31 AM PDT · by PghBaldy · 7 replies
    ABA Journal ^ | July 23 | Amanda Robert
    In an amicus brief filed with the U.S. Supreme Court on Monday, the ABA says: “Imposing governmental attorneys’ fees on patent applicants who choose civil actions under [the law] will hamper equal access to justice and chill the assertion of meritorious claims.” The Supreme Court is considering in Peter v. NantKwest Inc. whether the phrase “all the expenses of the proceedings” in a provision of U.S. patent law includes expenses incurred by the U.S. Patent and Trademark Office when its attorneys defend the office in litigation
  • United States Patent & Trademark Office denies THE™ initial application for Ohio State trademark

    09/11/2019 3:33:15 PM PDT · by C19fan · 32 replies
    NBC Sports ^ | September 11, 2019 | John Taylor
    Much to the delight of its rival up north, the pretentious meter was pegged in the middle of August when Ohio State confirmed that it had filed the paperwork seeking a trademark on the word “The” as it pertains to items being marketed with the university’s name. Buckeye Nation, of course, takes great pride in letting everyone know that they are THE Ohio State University at nearly every turn, and the university is simply looking to protect that brand of self-identification. For now, though, that initial application made to the United States Patent & Trademark Office has been denied
  • Facebook Denies Shadow Banning, Receives Patent for Shadow Banning

    08/01/2019 6:39:06 PM PDT · by E. Pluribus Unum · 22 replies
    The New American ^ | Thursday, 01 August 2019 | C. Mitchell Shaw
    Facebook has continually denied that it participates in the practice of shadow banning — a method of blocking a users’ posts or comments from everyone except the user who made the post or comment. But a newly granted patent shows that Facebook not only does practice shadow banning, but wants to protect — by patent — the method it uses for doing so. Despite the fact that Facebook executives denied the practice in congressional testimony in April, the company was awarded a patent by the U.S. Patent and Trademark Office (USPTO) earlier this month for an automated system that would...
  • The Orwellian Attack on Section 101

    06/17/2019 11:24:08 AM PDT · by Twotone · 11 replies
    American Spectator ^ | June 17, 2019 | Mytheos Holt
    Imagine the following scenario: You spend your life slaving away at building some ingenious new device in your garage. After years of painstaking work, testing, and sleepless nights, you finally produce your device, patent it, and take it to market. However, before you can take it to market, someone serves you with a lawsuit.
  • Gene Patent/Drug Pricing Concerns and Unintended Consequences Dominate Second Senate Hearing on 101

    06/06/2019 10:13:18 AM PDT · by Jagermonster · 2 replies
    IP Watchdog ^ | June 5, 2019 | Eileen McDermott
    “Hans Sauer of BIO said that it is easy to argue—after the heavy lifting of discovery and development has been done and a product has made it to market—that it should not be patented in the public interest. ‘As if innovative products fell from the sky and ought to go directly into the public domain…. It is right to encourage complaints about problems, but we must do so with an appreciation of the system’s longer-term benefits for society.’” Wednesday’s Senate hearing on patent eligibility reform, which began more than 30 minutes late due to votes on the floor, opened with...
  • First Senate Hearing on 101 Underscores That ‘There’s More Work to Be Done’

    06/05/2019 4:14:57 PM PDT · by Jagermonster · 3 replies
    IP Watchdog ^ | June 4, 2019 | Steve Brachmann & Eileen McDermott
    “I’ve spent 22 years on the Federal Circuit and nine years since dealing with patent cases and I cannot predict [under the current law] in a given case whether eligibility will be found or not found. If I can’t do it, how can bankers, venture capitalists [and] business executives make reliable predictions and sensible decisions?” – Judge Paul Michel The first of three scheduled hearings in which the Senate IP Subcommittee will hear testimony from a total of 45 witnesses on the subject of patent eligibility law raised many questions. While some read the proposed draft bill released by Congress...